Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
Flattish volume growth and subdued new launches were key factors for last month
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Subscribe To Our Newsletter & Stay Updated
